Elliott Green

CEO, Co-Founder

Dandelion Health

Jun 2020 - Current (6 years 1 month)

SVP, GM Financial Services and Employers

Clarify Health Solutions

Aug 2019 - Jun 2020 (11 months)

Commercial Strategy and Partnerships

Formation Bio

Jan 2018 - Dec 2019 (2 years)

VP Expansion and Strategic Partnerships

Oscar Health

Jan 2014 - Dec 2018 (5 years)

Sole lead on both joint ventures - Cleveland Clinic and Humana. Responsible for deal structuring, negotiation and full operational implementation planning, involving extensive cross-functional work plans and market entry strategies. - Achieved successful launches on both within compressed deadlines. - Required intricate knowledge of diverse internal operations and complex interlinked processes -Responsible for expansion to new geographies with physician/hospital systems or commercial partners. -Identified key opportunities, created the strategy and operationalised it. -Proven ability to support C-Suite/Board level engagements and build strategic relationships with key decision makers.

Director of Market Development and CIO

Ve Global

Jan 2012 - Dec 2014 (3 years)

• Responsible for Sales and Account Management team focusing on product delivery, revenue growth and customer satisfaction from the existing client base, managing a team of over 60 people. • Altered approach to business development to focus on high value-add active and prospective clients – grew from 0-3% to 12% month-on-month • Restructured the division, growing the team from 20 to 50 people • Delivered enhanced product marketing, improving client understanding of core product • Improved internal systems and processes to shorten the sales cycle by at least half. • Drove the blueprint for international expansion • Ve Interactive was the winner of the ‘Real-Time Marketing’ award at the 2014 Data Strategy Awards, which was based upon the effo

Emerging Markets - Head of Global Markets Client Strategy and Prop Trading (multiple positions)

JP Morgan

Sep 2003 - Jun 2012 (8 years 10 months)

- Head of Global Emerging Markets Growth Strategy: Cross Selling Initiative, London Redefined the EM product-marketing model to cross sell into other coverage areas, including Equities, Credit and Investment Banking. Core objective was to grow Emerging Markets revenue by at least 10% globally to in excess of $300 million per annum. • The Cross Selling Initiative created and unlocked new revenue streams in other sections of the bank, and consistently met its targets. • Undertook the process of marketing the EM product offering through a process of education, training and re-incentivisation helping to enable sales people to sell products outside their core proposition. -Head of EMEA Emerging Markets Client Marketing and Proprietary Tradin

About

Detail

Timeline

Résumé